News
Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 – The NEPA IV formulation was evaluated for safety in the AC setting.
Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania
39a Assemblea generale ordinaria di Farma Industria Ticino
Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai
Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association
On 15 May 2019 Farma Industria Ticino will be at the University Hospital Center (CHUV) in Lausanne looking for talents
Helsinn Supports Local Art Exhibition, ‘Lugano: Reflections of Light’ by Helidon Xhixha, curated by Eike D. Schmidt
CSC Pharmaceuticals announces the launch of the innovative migraine and pain treatment developed by APR Applied Pharma Research
Coronavirus
Progetto Talenti
Linkedin